Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative Analytical Performance of Various HbA1c Assays in Iran.
Razi F, Rahnamaye Farzami M, Ebrahimi SA, Nahid M, Bigdeli MG, Sheidaei A, Ghasemian A, Tootee A, Keramati T, Nasli Esfahani E, Larijani B, Pasalar P. Razi F, et al. Among authors: sheidaei a. Arch Iran Med. 2016 Jun;19(6):414-9. Arch Iran Med. 2016. PMID: 27293057
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18-55 years: Randomized, double-blind, placebo-controlled, phase I clinical trial.
Ansarifar A, Farahani RH, Rahjerdi AK, Ahi M, Sheidaei A, Gohari K, Rahimi Z, Gholami F, Basiri P, Moradi M, Jahangiri A, Naderi K, Ghasemi S, Khatami P, Honari M, Khodaverdloo S, Shooshtari M, Azin HM, Moradi S, Shafaghi B, Allahyari H, Monazah A, Poor AK, Bakhshande H, Taghva Z, Nia MK, Dodaran MS, Foroughizadeh M. Ansarifar A, et al. Among authors: sheidaei a. Vaccine X. 2023 Oct 27;15:100401. doi: 10.1016/j.jvacx.2023.100401. eCollection 2023 Dec. Vaccine X. 2023. PMID: 37941802 Free PMC article.
Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial.
Ahi M, Hamidi Farahani R, Basiri P, Karimi Rahjerdi A, Sheidaei A, Gohari K, Rahimi Z, Gholami F, Moradi M, Ghafoori Naeeni F, Saffar KN, Ghasemi S, Barati B, Moradi S, Monazah A, Pouranvari F, Forooghizadeh M. Ahi M, et al. Among authors: sheidaei a. Vaccines (Basel). 2022 Oct 26;10(11):1800. doi: 10.3390/vaccines10111800. Vaccines (Basel). 2022. PMID: 36366308 Free PMC article.
Is amyloid-β an innocent bystander and marker in Alzheimer's disease? Is the liability of multivalent cation homeostasis and its influence on amyloid-β function the real mechanism?
ManafiRad A, Farzadfar F, Habibi L, Azhdarzadeh M, Aghaverdi H, Tehrani KH, Lotfi M, Kehoe PG, Sheidaei A, Ghasemian A, Darzi ER, Mahmoodi R, Mahmoudi M. ManafiRad A, et al. Among authors: sheidaei a. J Alzheimers Dis. 2014;42(1):69-85. doi: 10.3233/JAD-140321. J Alzheimers Dis. 2014. PMID: 24787921
Equity Chasm in Megacities: Five Leading Causes of Death in Tehran.
Gohari K, Parsaeian M, Sheidaei A, Rahimzadeh S, Baghestani AR, Pourhoseingholi MA, Pazhuheian F, Saeedi Moghaddam S, Mansouri A, Naderimagham S, Kavousi A, Farzadfar F. Gohari K, et al. Among authors: sheidaei a. Arch Iran Med. 2015 Oct;18(10):622-8. Arch Iran Med. 2015. PMID: 26443245
103 results